Calogero Cipolla
Overview
Explore the profile of Calogero Cipolla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
444
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cipolla C, Gebbia V, DAgati E, Greco M, Mesi C, Scandurra G, et al.
Curr Oncol
. 2024 Dec;
31(12):7566-7574.
PMID: 39727680
Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancer cases. Sentinel lymph node biopsy (SLNB) has emerged as a less invasive alternative...
2.
Cipolla C, Gebbia V, DAgati E, Greco M, Mesi C, Scandurra G, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39409973
Background: In breast cancer (BC) patients, axillary management has undergone major improvements over the last few years, and efforts to identify the optimal strategy for the management of axillary surgery...
3.
DAmico G, Santonocito R, Grech G, Graceffa G, Cipolla C, Scalia F, et al.
Biology (Basel)
. 2024 Sep;
13(9).
PMID: 39336170
Background: The incidence of various types of cancer, for example, papillary thyroid carcinoma (PTC), is on the rise. Since therapeutic success depends greatly on early diagnosis, reliable diagnostic biomarkers must...
4.
Rossi M, Cammarata E, Cipolla C, Vieni S, Toia F, Cordova A
Plast Reconstr Surg Glob Open
. 2024 Jun;
12(6):e5882.
PMID: 38868620
Background: Patients with previous breast augmentation may need implant removal for mechanical complications or other causes. After prosthesis removal, the residual parenchyma can be reshaped through a mastopexy with rearrangement...
5.
Cipolla C, Lupo S, Grassi N, Battaglia M, Mesi C, Scandurra G, et al.
Anticancer Res
. 2024 Apr;
44(5):2047-2053.
PMID: 38677748
Background/aim: Sentinel lymph node biopsy (SLNB) is effective in patients with breast cancer (BC) and positive axillary lymph nodes undergoing neoadjuvant chemotherapy (NAC). However, the frequency with which axillary lymphadenectomy...
6.
Cordova A, Rossi M, Roggio T, Cammarata E, Cipolla C, Vieni S, et al.
Sci Rep
. 2024 Apr;
14(1):9226.
PMID: 38649704
In this article, we present a modification of the NS/SRM technique in which the mastopexy design for skin reduction is undertaken with a wide-base bipedicled (WIBB) flap. The WIBB flap...
7.
Cipolla C, Lupo S, Grassi N, Tutino G, Greco M, Eleonora D, et al.
World J Surg Oncol
. 2024 Apr;
22(1):100.
PMID: 38627759
Background: Some studies have suggested that axillary lymph node dissection (ALND) can be avoided in women with cN0 breast cancer with 1-2 positive sentinel nodes (SLNs). However, these studies included...
8.
Cipolla C, Vieni S, DAgati E, Grassi N, Genova P, Graceffa G, et al.
Anticancer Res
. 2023 Sep;
43(10):4643-4649.
PMID: 37772556
Background/aim: Clinical trials have shown that the sentinel lymph node biopsy (SLNB) is feasible for patients with cN1 breast carcinoma treated with neoadjuvant chemotherapy (NAC). This study aimed to evaluate...
9.
Fanale D, Corsini L, Pedone E, Randazzo U, Fiorino A, Di Piazza M, et al.
Crit Rev Oncol Hematol
. 2023 Aug;
190:104086.
PMID: 37536445
Germline BRCA1/2 alterations in the Homologous Recombination (HR) pathway are considered as main susceptibility biomarkers to Hereditary Breast and Ovarian Cancers (HBOC). The modern molecular biology technologies allowed to characterize...
10.
Cammarata E, Toia F, Rossi M, Cipolla C, Vieni S, Speciale A, et al.
Healthcare (Basel)
. 2023 Jun;
11(12).
PMID: 37372859
Women with BRCA gene mutations have a higher lifetime risk of developing breast cancer. Furthermore, cancer is usually diagnosed at a younger age compared to the wild-type counterpart. Strategies for...